一、基本情况
姓名 | 性别 | 出生年月 |
招生专业 | |||
高英堂 | 男 | 196808 | ||||
专业技术职务 |
行政职务 | |||||
研究员 | 室主任 | 生物化学与分子生物学 | ||||
招生类型 |
所在单位 | |||||
科学学位(硕) | 天津市第三中心医 院 | |||||
最后学历及学位 | ||||||
毕业院校 | 毕业时间 | 所学专业 | 所获学位 | |||
南开大学 | 2003.12 | 遗传学 | 博士学位 | |||
| 科学研究主要方向 | |||||
gaoyt816@163.com | 肝病的细胞及分子生物学基础与临床应用研究 | |||||
二、目前承担科研课题情况
项目名称(级别最高 3-5 项) | 项目来源 | 本人排名 | 本人可支配 经费(万) | 项目起止时间 |
1 基于 LifeLines 模式建设肝病患者的 生物资源库 | 市局科技资源平台建设项目 | 1 | 20 | 2013.11-2016 .5 |
2 院内感染阴沟肠杆菌的分子分型和 亲缘关系检测方法研究 | 天津市应用基础与前沿技术研 究计划项目 | 4 | 2 | 2015.4-2018. 3 |
三、发表论文论著情况
题目 | 刊物或出版社 | 本人排名 | 发表时间 | 收录情况 (SCI、EI) |
Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma |
Cancer Biomark |
通讯作者 |
2015.2 |
SCI |
Overexpression of squamous cell carcinoma antigen 1 is associated with the onset and progression of human hepatocellular carcinoma |
Arch Med Res | 并列第一 作者 |
2015.2 |
SCI |
Survivin is not a promising serological maker for the diagnosis of hepatocellular carcinoma | Oncol Lett | 2 | 2015.5 | SCI |
Diagnosis accuracy of serum glypican-3 in patients with hepatocellular carcinoma: a systematic review with meta-analysis |
Arch Med Res |
3 |
2014.10 |
SCI |
Hepatectomised patient sera promote hepatocyte differentiation of human-induced pluripotent stem cells |
Dig Liver Dis |
3 |
2014.8 |
SCI |
The role of interleukin-28b gene polymorphisms in chinese patients with chronic hepatitis C treated with pegylated interferon and ribavirin |
Hepat Mon |
2 |
2014.8 |
SCI |
Expression and clinical significance of livin protein in hepatocellular carcinoma2013;35(5) |
Dis Markers | 2(通讯作 者) |
2013.5 |
SCI |
Gradually increased Golgi protein 73 expression in the progression of benign liver diseases to precancerous lesions and hepatocellular carcinoma correlates with prognosis of patients |
Hepatol Res |
2 |
. 2013.11 |
SCI |
Expression and significance of microRNA-183 in hepatocellular carcinoma | Sci World J | 2 | . 2013.10 | SCI |
Analysis of microRNA expression profiles in human hepatitis B virus-related hepatocellular carcinoma |
Clin Lab |
3 |
2013.9 |
SCI |
四、主要业绩